Medical & Regulatory Disclaimer
Effective Date: October 2026
1. Not Medical Advice & No Doctor-Patient Relationship
The information, educational teachings, scientific hypotheses, video dialogues, and AI chat responses provided on The Human Energy Center website are strictly for educational and scientific research exploration. Nothing contained on this website creates a doctor-patient relationship between you and Fenton G. LeBon, MD or any affiliated healthcare practitioner.
Always seek the direct guidance of your licensed medical physician or other qualified health provider with any questions you may have regarding a medical condition, symptoms, or medication management. Never disregard professional medical advice or delay seeking it because of something you have read or listened to on this site.
2. Mandatory FDA Statement (DSHEA 1994)
3. Compounding Pharmacy Formulations (503A)
Injectable formulations (subcutaneous, intravenous) and concentrated intranasal formulations described on this site are customized compounded medications prepared pursuant to an individualized prescription from a licensed physician by state-licensed compounding pharmacies (such as PrecisionPharma FL and Shady Grove Pharmacy ML) in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act. Compounded medications are not approved by the FDA for safety or efficacy as new drugs.
4. FTC Material Financial Interest Disclosure
Dr. Fenton G. LeBon is a licensed physician in Florida and Co-Founder and CEO of Molecular World Health, Inc. (MWH). MWH develops NAD+ therapeutics and holds patent-pending status for nanoNAD+™ technology. MWH maintains licensing agreements with licensed compounding pharmacies dispensing nanoNAD+™. A direct material financial interest in nanoNAD+™ products and compounding royalties is hereby disclosed in full compliance with Federal Trade Commission (FTC) guidelines.